Skip to the page

Data / Form D filings / Turn Biotechnologies, Inc.

Turn Biotechnologies, Inc.: Form D filing

Turn Biotechnologies, Inc., a company in Mountain View, CA, filed a Form D with the SEC in 2023. The latest, on September 6, 2023, reports $29.1 million sold of a $43.9 million offering to 55 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
319 N. BERNARDO, Mountain View, CA, 94043
Phone
(833) 887-6246
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1992229

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 6, 2023New notice$43,867,224$29,132,219$14,735,00555Aug 22, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Vittorio Andres SebastianoDirector
Marco Andres QuartaDirector
Sergio Andres Ruiz-ChinchillaExecutive Officer
David Andres GobelDirector
Anja Andres KrammerExecutive Officer, Director
Ric Andres PetersonExecutive Officer

Other companies in California that filed recently

Every Form D from the week of Sep 4, 2023 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Turn Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.